In preclinical studies the orally administered drug, CVS-1123, proved effective in preventing blood clots without adverse side effects. * CytoTherapeutics Inc., of Providence, R.I., said a pilot clinical trial of its cell-containing implant of recombinant ciliary neurotrophic factor (CNTF) for treatment of amyotrophic lateral sclerosis (Lou Gehrig's disease) achieved delivery of CNTF to the central nervous system at the desired levels with no serious side effects...The drug is a human hormone

Advanced Tissue Sciences Inc., of La Jolla, Calif., completed enrollment of 65 patients in its pivotal clinical trial of Dermagraft-TC for treatment of severe burns...The drug is a human hormone derivative being evaluated in Phase I/II trials. * T Cell Sciences Inc., of Needham, Mass., said initial clinical trials of TP10 showed the compound reduced complement activation in patients with acute lung injuries

The NCI's Cancer Therapy Evaluation Program will collaborate with Canji on human clinical trials, which could be ready to begin in 1996. * Isis Pharmaceuticals Inc., of Carlsbad, Calif., said underwriters exercised their overallotment option to purchase 375,000 shares of stock at $10 each

clinical trials. * MicroGeneSys Inc., of Meriden, Conn., signed a multi- million dollar agreement with Connaught Laboratories Inc., of Swiftwater, Pa., to develop an influenza vaccine based on a genetically engineered version of the influenza virus hemagglutinin antigen

Imutec Corp., of Toronto, said it completed development and validation of a new potency assay for Virulizin, and is preparing to file documents to recommence clinical trials of the cancer drug in Canada, and start studies in the U.S. Trials were delayed in October 1994, while the company developed a reliable assay. * Procept Inc., of Cambridge, Mass., will reconfigure the dosing regimen in a Phase I/II trial of PRO 2000 for HIV

The grant will support expenses through Phase I clinical trials of the compound, which is derived from a microorganism. (c) 1997 American Health Consultants

Immucor Inc., of Norcross, Ga., began clinical trials of its automated blood bank system, the ABS 2000

The funding was awarded by the National Cancer Institute, the California Breast Cancer Research Program and the Small Business Innovation Research Program. * Immune Response Corp., of Carlsbad, Calif., began a Phase II clinical trial for psoriasis with a drug that the company described as synthetic peptides designed to inhibit the activation of T cells believed to be responsible for the disease

NeXstar issued 751,597 shares to takeover Supragen, which is developing drugs for T cell mediated diseases, in a deal valued at $11 million. * Protein Design Labs Inc., of Mountain View, Calif., began a clinical trial in Japan of its Smart M195 humanized mouse antibody to treat myeloid leukemia

NeXstar issued 751,597 shares to takeover Supragen, which is developing drugs for T cell mediated diseases, in a deal valued at $11 million. * Protein Design Labs Inc., of Mountain View, Calif., began a clinical trial in Japan of its Smart M195 humanized mouse antibody to treat myeloid leukemia

Immunomedics Inc., of Morris Plains, N.J., said clinical trials of its CEA-Scan diagnostic showed the test detected liver metastases in 15 of 19 patients with colorectal cancer

Alpha-Beta Technology Inc., of Worcester, Mass., filed an investigational new drug application with the FDA to begin clinical trials of Betafectin as a means of restoring cancer patients' bone marrow following chemotherapy...The 19 patients involved in the study had a broad variety of CEA-producing cancers, including colorectal, medullary thyroid, ovarian, breast and lung cancers. * Imre Corp., of Seattle, began a clinical trial of its Prosorba column to prevent kidney transplant rejections

Connaught is a subsidiary of France-based Pasteur Merieux Serums & Vaccins. * Sheffield Medical Technologies Inc., of New York and Houston, began a Phase I/IIA clinical trial with its drug, RBC-CD4, for HIV

in New York for alleged breach of contract related to the 1993 suspension of Centoxin clinical trials for sepsis. * Elan Corp

The new company will be called Boston Life Sciences and will trade under the symbol, BLSI, on the NASDAQ SmallCap market. * Interferon Sciences Inc., of New Brunswick, N.J., started a multicenter clinical trial of a topical formulation of its Interferon Alfa-n3 to treat human papillomavirus in women with HIV

The data came from the first of five Phase I/II clinical trials of the product, which was reported in the June issue of The Journal of Infectious Diseases. * Pharmos Corp., of New York, said it completed a Phase I trial in the U.K

clinical trial for treatment of chronic granulomatous disease...In the clinical trial, Somatix's retroviral vectors will be used to insert ex vivo a corrective gene into stem cells, which will then be expanded before being reinfused into the patients. * Takara Shuzo Co

Univax ended its funding of clinical trials of CryptoGAM as part of its recent business restructuring. (See BioWorld Today, May 16, 1995, p. 1.) * International Murex Technologies Corp., of Atlanta, will be listed on the NASDAQ National Market System board as of June 1 under the new symbol, MURX

Univax ended its funding of clinical trials of CryptoGAM as part of its recent business restructuring. (See BioWorld Today, May 16, 1995, p. 1.) * International Murex Technologies Corp., of Atlanta, will be listed on the NASDAQ National Market System board as of June 1 under the new symbol, MURX